# A Study to Evaluate the Effect of Age on the Pharmacokinetics, Safety and Tolerability of IV Rivipansel.

> **NCT02998099** · PHASE1 · COMPLETED · sponsor: **GlycoMimetics Incorporated** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Rivipansel

## Key facts

- **NCT ID:** NCT02998099
- **Lead sponsor:** GlycoMimetics Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-02
- **Final completion:** 2017-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02998099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02998099, "A Study to Evaluate the Effect of Age on the Pharmacokinetics, Safety and Tolerability of IV Rivipansel.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02998099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*